Lit Matters 2: HEART score

The HEART score helped standardize emergency department chest pain risk stratification before high-sensitivity troponin pathways became dominant. It still offers a fast bedside estimate of short-term major adverse cardiac events, especially for low-risk patients, but its role is now more supportive than central in hs-troponin era ACS evaluation.

HEART Score in Chest Pain

• Low-risk discharge signal: A HEART score of 0-3 identified a large low-risk group with about 98% freedom from 6-week MACE, making it useful for ED discharge and shared decision-making conversations.
• High-risk escalation group: Scores of 7-10 marked a cohort with roughly 50% 6-week MACE, a clear signal that chest pain patients need aggressive ACS evaluation rather than reassurance.
• Better than older scores: In low- and intermediate-risk patients, HEART outperformed TIMI and GRACE for short-term cardiac events, which is why it became such a practical ED tool.
• Single-troponin design era: This validation used only the first conventional troponin, not high-sensitivity assays, which explains why the score feels dated beside modern 2- to 3-hour hs-troponin pathways.
• Modern role shift: HEART remains easy to calculate and useful at the bedside, but hs-troponin algorithms now lead contemporary chest pain pathways. We get into where HEART still fits in the chapter.